Nymox Pharmaceutical Corp (NYMXF)

CIK 1018735 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nymox Pharmaceutical Corp.

Recent SEC filings

FiledFormAccession number
Aug 31, 20266-K0001640334-26-001427
Aug 7, 20266-K0001640334-26-001291
Jun 3, 20266-K0001640334-26-000983
Mar 27, 20266-K0001640334-26-000562
Oct 22, 20256-K0001640334-25-001864
Oct 22, 20256-K0001640334-25-001862
Sep 23, 20256-K0001640334-25-001701
Jun 3, 202520-F0001640334-25-000972
May 22, 20256-K0001640334-25-000923
May 1, 2025NT 20-F0001640334-25-000728
Mar 11, 20256-K0001640334-25-000362
Jan 2, 20256-K0001640334-25-000006
Dec 17, 20246-K0001640334-24-001904
Aug 29, 202420-F0001640334-24-001383
Jul 18, 20246-K0001640334-24-001139
Jul 16, 20246-K0001640334-24-001122
May 13, 20246-K0001640334-24-000763
Mar 28, 20246-K0001640334-24-000510
Nov 15, 20236-K0001640334-23-002155
Nov 9, 20236-K0001640334-23-002040
Nov 6, 20236-K0001640334-23-002021
Oct 26, 20236-K0001640334-23-001964
Sep 25, 20236-K0001640334-23-001739
Sep 8, 202325-NSE0001354457-23-000656
Aug 29, 20236-K0001640334-23-001653